Neuralink gets FDA approval for ‘in-human’ trials of its brain-computer interface
The Neuralink device is designed to be surgically implanted and, according to CEO Elon Musk, will eventually be marketed to the general public.
The Neuralink device is designed to be surgically implanted and, according to CEO Elon Musk, will eventually be marketed to the general public.
Original source
Read on CointelegraphRelated market context
SEC targets 20-year-old rule standing between Wall Street and blockchain trading
The Securities and Exchange Commission (SEC) is moving to dismantle a stock-trading rule that has governed Wall Street for two dec...
Crypto exchanges are opening a two-front war for the stock market
Binance, Kraken, Bybit, and Gemini are moving to add US stocks and ETFs to their crypto trading apps, making a direct play for the...
Strategy’s Michael Saylor targets $15-30T for Bitcoin-backed credit instruments
Saylor's Bitcoin-backed credit strategy could reshape global finance, integrating crypto into mainstream credit markets and alteri...
Aurora’s Polymarket sponsorship gets its first Major spotlight at IEM Cologne 2026
Polymarket's sponsorship of Aurora at IEM Cologne 2026 highlights the growing intersection of crypto markets and esports, raising...
Ripple chases AI’s machine economy as XRPL stablecoins near $1 billion
Stablecoin liquidity on the XRP Ledger (XRPL) has nearly doubled over the past month, putting the network within reach of a $1 bil...
Inter Milan eyes four summer targets as club plots sell-to-buy strategy worth €90 million
Inter Milan's sell-to-buy strategy could reshape their squad dynamics, impacting Serie A competitiveness and influencing future tr...